Quan Capital is a healthcare-focused global venture capital firm based in China that identifies, incubates, and grows next-generation life sciences companies. The firm aims to explore disruptive solutions to critical healthcare problems impacting millions of lives, investing in pioneers of breakthrough therapies and cutting-edge technologies. They also invest in leading players that fulfill the rapidly growing needs in a nascent innovation-driven ecosystem in China. Quan Capital leverages strong expertise in both science and business to identify and nurture the next generation of great companies. They are deeply involved in company building, providing hands-on support for strategy, operation, and development. The firm contributes broad networks to bridge and smooth companies' transformation between different development stages, and maximize company value across the value chain and varying geographies. They provide “smart capital” that brings broad scientific knowledge, cross-functional operational experiences, deep company-building leadership guidance, extensive global & local network, and a unique combination of global vision/quality and China strength.
Preferred startup development maturity for initial funding deployment.
Therapeutic biotech/pharma, Enabling technologies/High-end specialty services, Companion diagnostic & Precision medicine
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...